Security key
00287Y109
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 1,287,075,518
- Total 13F value
- $238,891,433,790
- Share change
- +26,417,046
- Put/Call ratio
- 62%
- SEC-reported price per share
- $185.62
- Number of holders
- 3,742
- Value change
- +$4,866,082,603
- Number of buys
- 1,822
- Number of sells
- 1,624
- Shares outstanding
- 1,769,960,826
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
3,742
Top holders
10
ABBV full security history
Ownership snapshot
Full 13F holder table
AbbVie Inc. SEC filings
AbbVie Inc. company facts
AbbVie Inc. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of ABBV - AbbVie Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Glenn F. Tilton
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
09 May 2025
3/4/5
13F
Lead comparable stake: 0%
Showing 1-6 of 15 holder rows.
Quick read
Glenn F. Tilton leads the comparable SEC ownership view at 0%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Glenn F. Tilton's linked filing trail.
Comparable ownership
Top 5
Glenn F. Tilton
0%
VANGUARD GROUP INC
9.8%
BlackRock, Inc.
8.2%
STATE STREET CORP
4.5%
JPMORGAN CHASE & CO
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Glenn F. Tilton |
3/4/5
Director
|
0%
|
$9,043,418
51,914 shares
|
— | 09 May 2025 |
| VANGUARD GROUP INC |
13F
Company
|
9.8%
|
$36,439,271,075
173,917,865 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
8.2%
|
$30,564,388,367
145,878,142 shares
|
— | 31 Mar 2025 |
| STATE STREET CORP |
13F
Company
|
4.5%
|
$16,753,840,846
79,962,967 shares
|
— | 31 Mar 2025 |
| JPMORGAN CHASE & CO |
13F
Company
|
3.1%
|
$11,472,157,159
54,754,470 shares
|
— | 31 Mar 2025 |
| MORGAN STANLEY |
13F
Company
|
2.3%
|
$8,621,693,054
41,149,734 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3,742
Shares
1,287,075,518
Rows available
3,742
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
3,780
Q2 2025 holders
3,742
Holder diff
-38
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|